Acute Coronary Syndrome Clinical Trial
— POC-ETOfficial title:
Point of Care Evaluation of High-sensitivity Cardiac Troponin
Verified date | April 2024 |
Source | University of Edinburgh |
Contact | Chris Tuck |
chris.tuck[@]ed.ac.uk | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
In this observational research project the investigators wish to test new technologies that could allow them to either detect or rule out heart attacks earlier. Currently, when a patient attends the Emergency Department with symptoms that could be due to a heart attack, the patient has a blood test taken from a vein in the arm. This is sent to a laboratory to measure the level of a protein called troponin that is released from the heart when it is damaged. Doctors and nurses use the level of troponin measured in that blood sample, along with a tracing of the heart and an assessment of symptoms, to decide whether the patient is having a heart attack. On average, it takes about 2 hours from the patient arriving at hospital to the doctor or nurse receiving the blood test result so they can make this diagnosis. A device has been designed that can measure troponin by using a drop of blood from a finger prick with the result available in around 10 minutes. This means that if a patient is having a heart attack we can diagnose it earlier and give them treatment. Previous studies have also showed that the majority of patients who attend hospital with chest pain ultimately do not have a heart attack. With this new device the investigators hope to be able to reassure these patients that their symptoms are not due to a heart attack, so the clinical team can concentrate on finding out what else could be causing their chest pain, and ultimately discharge them earlier. The investigators aim to find the best way to use this new device and look at the impact this device has on the length of time from sample to diagnosis and time spent in hospital.
Status | Recruiting |
Enrollment | 1000 |
Est. completion date | November 30, 2025 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Presenting to hospital with symptoms of suspected acute coronary syndrome - Age 18 years and over Exclusion Criteria: - Patients with ST-segment elevation on the electrocardiogram - Patients presenting with an out-of-hospital cardiac arrest - Patients unable or unwilling to give informed consent - Patients unable or unwilling to comply with study protocol - Previous enrolment in this study |
Country | Name | City | State |
---|---|---|---|
United Kingdom | NHS Lothian | Edinburgh |
Lead Sponsor | Collaborator |
---|---|
University of Edinburgh | British Heart Foundation, NHS Grampian, Siemens Healthcare Diagnostics Ltd |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Time from presentation to rule-out or rule-in myocardial infarction | Time of index presentation until the time of reporting of the troponin result that rules in or rules out myocardial infarction, assessed up to the end of study follow up (12 months) | ||
Other | Duration of stay in hospital (index) | Time from index presentation until the time of discharge from hospital, assessed up to the end of study follow up (12 months) | ||
Other | Duration of stay in Emergency Department | Time from index presentation until the time of discharge from the Emergency Department, assessed up to the end of study follow up (12 months) | ||
Other | Inter-assay coefficient of variation | During index admission, assessed up to 36 hours following enrolment | ||
Primary | Type 1, 4b or 4c myocardial infarction or cardiac death | Index presentation to 30 days | ||
Secondary | Any myocardial infarction | Index presentation to 1 year | ||
Secondary | Cardiac death | Index presentation to 1 year | ||
Secondary | Any myocardial infarction or cardiac death | Index presentation to 1 year | ||
Secondary | Cardiovascular death | Index presentation to 1 year | ||
Secondary | All-cause death | Index presentation to 1 year | ||
Secondary | Reattendance with suspected acute coronary syndrome | Index presentation to 1 year | ||
Secondary | Unplanned coronary revascularization | Following index presentation to 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT05412927 -
AngelMed Guardian® System PMA Post Approval Study
|
||
Completed |
NCT02750579 -
Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?
|
N/A | |
Completed |
NCT04102410 -
Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients
|
N/A | |
Enrolling by invitation |
NCT03342131 -
Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome
|
N/A | |
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Enrolling by invitation |
NCT04676100 -
International CR Registry
|
||
Completed |
NCT03590535 -
5th Generation cTnT in ED ACS
|
||
Recruiting |
NCT05437900 -
INSIGHTFUL-FFR Clinical Trial
|
Phase 4 | |
Completed |
NCT05551429 -
Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
|
||
Terminated |
NCT04316481 -
IDE-ALERTS Continued Access Study
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT04852146 -
Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
|
||
Active, not recruiting |
NCT02892903 -
In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes?
|
N/A | |
Not yet recruiting |
NCT02871622 -
BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
|
N/A | |
Completed |
NCT04077229 -
Piloting Text Messages to Promote Positive Affect and Physical Activity
|
N/A | |
Completed |
NCT02944123 -
Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
|
Phase 3 | |
Active, not recruiting |
NCT02922140 -
The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit
|
N/A | |
Terminated |
NCT02620202 -
Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain
|